Overview
- The peer-reviewed study was published today in Cell Biomaterials with senior authors Ana Jaklenec and Robert Langer and lead author Erika Wang.
- In rat models of myocardial infarction, the patch increased survival by 33%, cut damaged tissue by 50%, and improved cardiac output compared with no treatment or intravenous delivery.
- The alginate/PEGDA sheet houses PLGA microparticles tuned to release at days 1-3, 7-9, and 12-14 after implantation.
- Sequential agents were neuregulin-1, VEGF, and the anti-fibrotic small molecule GW788388, with the first two previously tested in clinical trials.
- The biodegradable material thins to a near layer over about a year, and the team plans further animal testing while evaluating stent-based deployment to reduce surgical burden.